Placebo in Acupuncture
NCT01054495 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2010-01-29
Summary
Placebo control in acupuncture research is challenging and difficult. The primary objective of the study is to explore a study design comparing stimulation by real acupuncture needle, sham acupuncture needle and laser. The research question is whether a patient is capable of discriminate different stimulation modality when studying acupuncture stimulation for nausea in early pregnancy. The study is planned as a pilot study including 20 women in each of the three study groups, all-together 60 pregnant women. Intervention will consist of standardised 15 minutes stimulation of acupuncture point pericardium 6 by, either two acupuncture needles, two sham acupuncture needle or two laser devices. All participating women are told that they will get different stimulation at an acupuncture point with potential effect on nausea. The women will record their daily symptoms during a 4 day run-in period, a 3 day intervention period, and thereafter a 4 day follow-up period after treatment in accordance with previous research methodology. In addition, the women will record how they experience the three different stimulations of acupuncture points. The results from the study could be important for planning of future studies where the blinding issue with regard to acupuncture is challenged.
Conditions
Interventions
- DRUG
-
Acupuncture
The acupuncture needles are inserted in PC 6 bilaterally at the acupuncture point Pericardium 6 (PC6) on each forearm (fig 2). According to the "cun" measurement system of Traditional Chinese Medicine (TCM), the points are located on the palmar surface of anterior forearm at a distance equivalent to the combined width of the women's middle three fingers, proximal to the most prominent wrist crease, and between the tendons of palmaris longus and flexor carpi radialis. We try to keep the depth of the needling to approximately 1,5 cm. At insertion of the acupuncture needle, DeQi is obtained and the needle is then left without any further manipulation/ stimulation (even method) in situ for 15 minutes.
- DEVICE
-
Sham acupuncture
A sham acupuncture needle is placed at PC 6 bilaterally and the tactile stimuli of the skin during the procedure should be obtained. The sham acupuncture needle is then left at site for 15 minutes without any further manipulation/stimulation.
- DEVICE
-
Laser acupuncture
A laser is placed in a stand, pointing at PC 6 bilaterally, and left at site for 15 minutes without any further manipulation/stimulation.
Sponsors & Collaborators
-
Norwegian Acupuncture College
collaborator UNKNOWN -
National Research Centre of Complementary and Alternative Medicine, Norway
lead OTHER
Principal Investigators
-
Arne Johan Norheim, PhD · The National research center in Complementary and Alternative Medicine
Study Design
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- Norway
Study Locations
More Related Trials
-
The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting
NCT02369107 ·Status: UNKNOWN ·Phase: NA
-
The Different Effectiveness of Single Acupoint(PC6 or CV12) vs Matching Acupoints(PC6 and CV12) in Chemotherapy-induced Nausea and Vomiting
NCT02195908 ·Status: COMPLETED ·Phase: NA
-
Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response
NCT03675321 ·Status: COMPLETED ·Phase: NA
-
The Comparative Study on the Efficacy and Safety of Single Acupoint and Matching Acupoints
NCT03061396 ·Status: UNKNOWN ·Phase: NA
-
Comparative Effect Study Between Distal-proximal Point Association and Local Distribution Point Association in Chemotherapy-induced Nausea and Vomiting
NCT02478047 ·Status: UNKNOWN ·Phase: NA
-
A Study of TAK-105 in Healthy Adults
NCT04964258 ·Status: COMPLETED ·Phase: PHASE1
-
Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV)
NCT02767791 ·Status: COMPLETED ·Phase: NA
-
The Effect of Scent on Pregnancy Induced Nausea, Vomiting, and Quality of Life
NCT03513536 ·Status: COMPLETED ·Phase: NA
-
Placebo-controlled, Randomized Trial of a Simplified Biofeedback Technique for the Treatment of Rumination
NCT02402946 ·Status: COMPLETED ·Phase: NA
-
Do Pharyngeal Packs During Orthognathic Surgery Reduce Postoperative Nausea and Vomiting
NCT02049619 ·Status: UNKNOWN ·Phase: NA
-
Auricular Neurostimulation for Cyclic Vomiting Syndrome
NCT03434652 ·Status: COMPLETED ·Phase: NA
-
Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
NCT00003817 ·Status: COMPLETED ·Phase: PHASE2
-
Acupuncture for Chemical Therapy Induced Nausea and Vomiting
NCT02842307 ·Status: COMPLETED ·Phase: NA
-
Electric Stimulation on Nausea and Vomit Chemotherapy Induced
NCT03145727 ·Status: UNKNOWN ·Phase: NA
-
Aromatherapy as Treatment for n/v of Pregnancy
NCT03609567 ·Status: COMPLETED ·Phase: NA
-
Effect of Acetazolamide on Postural Control in Lowlanders Older Than 40 Years at Altitude
NCT03536429 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers
NCT02177890 ·Status: COMPLETED ·Phase: NA
-
Treament of Rumination
NCT04167371 ·Status: COMPLETED ·Phase: NA
-
Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers
NCT02466711 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide
NCT01069536 ·Status: COMPLETED ·Phase: NA
-
EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors
NCT06769165 ·Status: RECRUITING ·Phase: NA
-
Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea
NCT01556932 ·Status: COMPLETED ·Phase: NA
-
Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo
NCT02253524 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of TAK-951 in Healthy Adults
NCT04486950 ·Status: COMPLETED ·Phase: PHASE1
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED